1 | 1 | | 88R10180 MCF-D |
---|
2 | 2 | | By: Tinderholt H.B. No. 4754 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to health benefit plan coverage for and prohibitions on |
---|
8 | 8 | | gender transitioning procedures and treatments provided to certain |
---|
9 | 9 | | individuals; creating a criminal offense. |
---|
10 | 10 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
11 | 11 | | SECTION 1. This Act may be cited as the Texas Millstone Act. |
---|
12 | 12 | | SECTION 2. Chapter 161, Health and Safety Code, is amended |
---|
13 | 13 | | by adding Subchapter X to read as follows: |
---|
14 | 14 | | SUBCHAPTER X. GENDER TRANSITION PROCEDURES OR TREATMENTS |
---|
15 | 15 | | Sec. 161.701. DEFINITIONS. In this subchapter: |
---|
16 | 16 | | (1) "Biological sex" means the biological indication |
---|
17 | 17 | | of male or female in the context of reproductive potential or |
---|
18 | 18 | | capacity, such as sex chromosomes, naturally occurring sex |
---|
19 | 19 | | hormones, gonads, and nonambiguous internal and external genitalia |
---|
20 | 20 | | present at birth, without regard to an individual's psychological, |
---|
21 | 21 | | chosen, or subjective experience of gender. |
---|
22 | 22 | | (2) "Cross-sex hormones" means: |
---|
23 | 23 | | (A) testosterone or other androgens provided to a |
---|
24 | 24 | | biological female in a more potent amount than would naturally |
---|
25 | 25 | | occur in a healthy biological female; or |
---|
26 | 26 | | (B) estrogen provided to a biological male in a |
---|
27 | 27 | | more potent amount than would naturally occur in a healthy |
---|
28 | 28 | | biological male. |
---|
29 | 29 | | (3) "Gender" means the psychological, behavioral, |
---|
30 | 30 | | social, and cultural aspects of being male or female. |
---|
31 | 31 | | (4) "Gender reassignment surgery" means a medical |
---|
32 | 32 | | procedure performed for the purpose of surgically altering or |
---|
33 | 33 | | removing healthy anatomical characteristics typical for the |
---|
34 | 34 | | individual's biological sex to instill physiological or anatomical |
---|
35 | 35 | | characteristics that resemble a sex different than the individual's |
---|
36 | 36 | | biological sex. The term includes genital or nongenital gender |
---|
37 | 37 | | reassignment surgery performed for the purpose of assisting an |
---|
38 | 38 | | individual with a gender transition. |
---|
39 | 39 | | (5) "Gender transition" means the process by which an |
---|
40 | 40 | | individual progresses from identifying with and living as the |
---|
41 | 41 | | gender that corresponds to the individual's biological sex to |
---|
42 | 42 | | identifying with and living as a gender different than the |
---|
43 | 43 | | individual's biological sex. The term includes social, legal, or |
---|
44 | 44 | | physical changes to an individual. |
---|
45 | 45 | | (6) "Gender transition procedure or treatment" means a |
---|
46 | 46 | | medical or surgical procedure or treatment, including a physician's |
---|
47 | 47 | | services, inpatient and outpatient hospital services, and |
---|
48 | 48 | | prescription drugs, related to gender transition that seeks to: |
---|
49 | 49 | | (A) alter or remove anatomical characteristics |
---|
50 | 50 | | typical for the individual's biological sex; or |
---|
51 | 51 | | (B) instill physiological or anatomical |
---|
52 | 52 | | characteristics that resemble a sex different from the individual's |
---|
53 | 53 | | biological sex, including: |
---|
54 | 54 | | (i) medical services that provide |
---|
55 | 55 | | puberty-blocking drugs, cross-sex hormones, or other mechanisms to |
---|
56 | 56 | | promote the development of feminizing or masculinizing features in |
---|
57 | 57 | | the opposite biological sex; and |
---|
58 | 58 | | (ii) genital or nongenital gender |
---|
59 | 59 | | reassignment surgery performed for the purpose of assisting an |
---|
60 | 60 | | individual with a gender transition. |
---|
61 | 61 | | (7) "Genital gender reassignment surgery" means a |
---|
62 | 62 | | medical procedure related to an individual's genitals and performed |
---|
63 | 63 | | for the purpose of assisting the individual with a gender |
---|
64 | 64 | | transition, including: |
---|
65 | 65 | | (A) surgical procedures such as penectomy, |
---|
66 | 66 | | orchiectomy, vaginoplasty, clitoroplasty, or vulvoplasty for |
---|
67 | 67 | | biologically male patients or hysterectomy or oophorectomy for |
---|
68 | 68 | | biologically female patients; |
---|
69 | 69 | | (B) reconstruction of the fixed part of the |
---|
70 | 70 | | urethra with or without a metoidioplasty; or |
---|
71 | 71 | | (C) phalloplasty, vaginectomy, scrotoplasty, or |
---|
72 | 72 | | implantation of erection or testicular prostheses for biologically |
---|
73 | 73 | | female patients. |
---|
74 | 74 | | (8) "Health care professional" means an individual |
---|
75 | 75 | | other than a physician who is licensed, certified, or otherwise |
---|
76 | 76 | | authorized by this state's laws to administer health care in the |
---|
77 | 77 | | ordinary course of business or practice of a profession. |
---|
78 | 78 | | (9) "Nongenital gender reassignment surgery" means a |
---|
79 | 79 | | medical procedure that is not a genital gender reassignment surgery |
---|
80 | 80 | | and is performed for the purpose of assisting an individual with a |
---|
81 | 81 | | physical gender transition, including the following surgical |
---|
82 | 82 | | procedures: |
---|
83 | 83 | | (A) for either a biological male or female: |
---|
84 | 84 | | (i) liposuction or lipofilling; or |
---|
85 | 85 | | (ii) various aesthetic procedures; |
---|
86 | 86 | | (B) for a biological male: |
---|
87 | 87 | | (i) augmentation mammoplasty; |
---|
88 | 88 | | (ii) facial feminization surgery; |
---|
89 | 89 | | (iii) voice feminization surgery; |
---|
90 | 90 | | (iv) thyroid cartilage reduction; |
---|
91 | 91 | | (v) gluteal augmentation; or |
---|
92 | 92 | | (vi) hair reconstruction; or |
---|
93 | 93 | | (C) for a biological female: |
---|
94 | 94 | | (i) subcutaneous mastectomy; |
---|
95 | 95 | | (ii) voice masculinization surgery; or |
---|
96 | 96 | | (iii) pectoral implants. |
---|
97 | 97 | | (10) "Physician" means a person licensed to practice |
---|
98 | 98 | | medicine in this state. |
---|
99 | 99 | | (11) "Puberty-blocking drug" means a drug used to |
---|
100 | 100 | | delay or suppress normal puberty development in children for the |
---|
101 | 101 | | purpose of assisting an individual with a gender transition, |
---|
102 | 102 | | including: |
---|
103 | 103 | | (A) for a biological male, a |
---|
104 | 104 | | gonadotropin-releasing hormone analogue or other synthetic drug |
---|
105 | 105 | | prescribed to stop luteinizing hormone secretion and testosterone |
---|
106 | 106 | | secretion; or |
---|
107 | 107 | | (B) for a biological female, a synthetic drug |
---|
108 | 108 | | prescribed to stop the production of estrogen and progesterone. |
---|
109 | 109 | | (12) "Public money" means money of this state, a state |
---|
110 | 110 | | agency, or a political subdivision. |
---|
111 | 111 | | Sec. 161.702. APPLICABILITY. This subchapter does not |
---|
112 | 112 | | apply to: |
---|
113 | 113 | | (1) a procedure, treatment, or service provided to an |
---|
114 | 114 | | individual who is born with a medically verifiable genetic disorder |
---|
115 | 115 | | of sex development, including: |
---|
116 | 116 | | (A) 46,XX chromosomes with virilization; |
---|
117 | 117 | | (B) 46,XY chromosomes with undervirilization; or |
---|
118 | 118 | | (C) both ovarian and testicular tissue; |
---|
119 | 119 | | (2) a procedure, treatment, or service provided to an |
---|
120 | 120 | | individual who does not have the normal sex chromosome structure, |
---|
121 | 121 | | sex steroid production, or sex steroid hormone action for male or |
---|
122 | 122 | | female as determined by a physician through genetic testing or |
---|
123 | 123 | | biochemical testing; |
---|
124 | 124 | | (3) treatment of an infection, injury, disease, or |
---|
125 | 125 | | disorder that has been caused by or exacerbated by the performance |
---|
126 | 126 | | of a gender transition procedure or treatment, regardless of |
---|
127 | 127 | | whether: |
---|
128 | 128 | | (A) the gender transition procedure or treatment |
---|
129 | 129 | | was performed in accordance with state and federal law; or |
---|
130 | 130 | | (B) funding for the gender transition procedure |
---|
131 | 131 | | or treatment is permissible under this subchapter; or |
---|
132 | 132 | | (4) a procedure undertaken because the individual |
---|
133 | 133 | | suffers from a physical disorder, injury, or illness that would, as |
---|
134 | 134 | | certified by a physician, place the individual in imminent danger |
---|
135 | 135 | | of death or impairment of a major bodily function unless the |
---|
136 | 136 | | procedure is performed. |
---|
137 | 137 | | Sec. 161.703. CONSTRUCTION OF SUBCHAPTER. This subchapter |
---|
138 | 138 | | may not be construed to deny, impair, or otherwise affect any right |
---|
139 | 139 | | or authority of the attorney general, this state, or any agency, |
---|
140 | 140 | | officer, or employee of this state, acting under any law other than |
---|
141 | 141 | | this subchapter, to bring or intervene in an action brought under |
---|
142 | 142 | | this subchapter. |
---|
143 | 143 | | Sec. 161.704. PROHIBITED PROVISION OF GENDER TRANSITION |
---|
144 | 144 | | PROCEDURES OR TREATMENTS. A physician or health care professional, |
---|
145 | 145 | | including a physician or health care professional employed by or |
---|
146 | 146 | | practicing in a facility owned by this state or a political |
---|
147 | 147 | | subdivision, may not: |
---|
148 | 148 | | (1) provide a gender transition procedure or treatment |
---|
149 | 149 | | to an individual younger than 26 years of age; or |
---|
150 | 150 | | (2) refer an individual younger than 26 years of age to |
---|
151 | 151 | | a physician or health care professional for a gender transition |
---|
152 | 152 | | procedure or treatment. |
---|
153 | 153 | | Sec. 161.705. PROHIBITED USE OF PUBLIC MONEY. Public money |
---|
154 | 154 | | may not directly or indirectly be used, granted, paid, or otherwise |
---|
155 | 155 | | distributed to a person who provides gender transition procedures |
---|
156 | 156 | | or treatment to individuals younger than 26 years of age. |
---|
157 | 157 | | Sec. 161.706. PROHIBITED MEDICAID REIMBURSEMENT. The |
---|
158 | 158 | | commission may not provide Medicaid reimbursement to a provider for |
---|
159 | 159 | | a gender transition procedure or treatment to an individual younger |
---|
160 | 160 | | than 26 years of age. |
---|
161 | 161 | | Sec. 161.707. CRIMINAL OFFENSE. (a) A physician or health |
---|
162 | 162 | | care professional who knowingly violates Section 161.704 commits an |
---|
163 | 163 | | offense. |
---|
164 | 164 | | (b) An offense under this section is a state jail felony. |
---|
165 | 165 | | (c) An indictment for an offense under this section must be |
---|
166 | 166 | | presented within 40 years from the date of the commission of the |
---|
167 | 167 | | offense, and not afterward. |
---|
168 | 168 | | Sec. 161.708. DISCIPLINARY ACTION. (a) The Texas Medical |
---|
169 | 169 | | Board or another state regulatory agency with jurisdiction over a |
---|
170 | 170 | | health care provider subject to Section 161.704 shall revoke the |
---|
171 | 171 | | license, certification, or authorization of a physician or health |
---|
172 | 172 | | care provider who the board or agency determines has violated that |
---|
173 | 173 | | section. |
---|
174 | 174 | | (b) Disciplinary action described by Subsection (a) must be |
---|
175 | 175 | | taken not later than the 40th anniversary of the date of the |
---|
176 | 176 | | violation of Section 161.704. |
---|
177 | 177 | | Sec. 161.709. CIVIL ACTION. (a) Notwithstanding any other |
---|
178 | 178 | | law, an individual may bring an action for damages incurred as a |
---|
179 | 179 | | result of a gender transition procedure or treatment performed on |
---|
180 | 180 | | the individual: |
---|
181 | 181 | | (1) through the individual's parent, guardian, or next |
---|
182 | 182 | | friend, if the individual is under 18 years of age; and |
---|
183 | 183 | | (2) in the individual's own name, not later than the |
---|
184 | 184 | | 40th anniversary after the date the individual attains 18 years of |
---|
185 | 185 | | age. |
---|
186 | 186 | | (b) A court may award to the prevailing claimant: |
---|
187 | 187 | | (1) compensatory damages; |
---|
188 | 188 | | (2) injunctive relief; |
---|
189 | 189 | | (3) declaratory relief; and |
---|
190 | 190 | | (4) any other appropriate relief. |
---|
191 | 191 | | (c) A court shall award a claimant prevailing in an action |
---|
192 | 192 | | brought under this section reasonable attorney's fees incurred in |
---|
193 | 193 | | bringing the action. |
---|
194 | 194 | | (d) Notwithstanding any other law, an action brought under |
---|
195 | 195 | | this section may be commenced, and relief may be granted, in a |
---|
196 | 196 | | judicial proceeding without regard to whether the individual |
---|
197 | 197 | | commencing the action has sought or exhausted available |
---|
198 | 198 | | administrative remedies. |
---|
199 | 199 | | Sec. 161.710. ATTORNEY GENERAL ENFORCEMENT. (a) The |
---|
200 | 200 | | attorney general may bring an action to enforce this subchapter. |
---|
201 | 201 | | (b) In an action brought under this section, the court may |
---|
202 | 202 | | award the attorney general injunctive or declaratory relief and |
---|
203 | 203 | | reasonable attorney's fees and costs incurred in bringing the |
---|
204 | 204 | | action. |
---|
205 | 205 | | SECTION 3. If before implementing any provision of this Act |
---|
206 | 206 | | a state agency determines that a waiver or authorization from a |
---|
207 | 207 | | federal agency is necessary for implementation of that provision, |
---|
208 | 208 | | the agency affected by the provision shall request the waiver or |
---|
209 | 209 | | authorization and may delay implementing that provision until the |
---|
210 | 210 | | waiver or authorization is granted. |
---|
211 | 211 | | SECTION 4. This Act takes effect September 1, 2023. |
---|